(Q35171703)

6 August 2017

Has adjuvant treatment of breast cancer had an unfair trial? (English)

1 reference

6 August 2017

Mittra I

1

1 reference

PubMed ID

2271858

6 August 2017

language of work or name

English

0 references

publication date

1 December 1990

1 reference

6 August 2017

3

1 reference

inferred from page(s)

published in

The BMJ

1 reference

6 August 2017

301

1 reference

6 August 2017

6764

1 reference

6 August 2017

1317-1319

1 reference

Why data bases should not replace randomized clinical trials

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

A prognostic index in primary breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Assessing apparent treatment--covariate interactions in randomized clinical trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Prognostic factors for recurrence and survival in human breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

DNA ploidy and survival in breast cancer patients.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Statistical tools for subset analysis in clinical trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Mechanism of action of adjuvant chemotherapy in early breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Approaches to monitoring clinical trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

The pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

Predicting breast cancer recurrence.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664434

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

27 September 2018

1 reference

12 December 2020

Dose-intense adjuvant treatment of high-risk breast cancer

1 reference

12 December 2020

Steroid-hormone receptors in breast cancer

1 reference

12 December 2020

Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values

1 reference

12 December 2020

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

12 December 2020

Why do we need some large, simple randomized trials?

1 reference

12 December 2020

A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers

1 reference

12 December 2020

Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics

1 reference

12 December 2020

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial

1 reference

12 December 2020

Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer

1 reference

12 December 2020

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

12 December 2020

10.1136/BMJ.301.6764.1317

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

PubMed ID

2271858